Embryonal Tumor with Multilayered Rosettes Overview
Learn About Embryonal Tumor with Multilayered Rosettes
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Robert Irwin is a Pediatrics provider in Tacoma, Washington. Dr. Irwin and is rated as an Experienced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Hepatoblastoma, Gliomatosis Cerebri, Embryonal Tumor with Multilayered Rosettes, Classical Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Irwin is currently accepting new patients.
Multicare Health System
Natalie Xu is a Radiation Oncologist in Tacoma, Washington. Dr. Xu and is rated as an Experienced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Breast Cancer, Pleuropulmonary Blastoma, Angiosarcoma, and Prostate Cancer. Dr. Xu is currently accepting new patients.
Michael Harris is a Hematologist Oncology specialist and a Hematologist in Puyallup, Washington. Dr. Harris and is rated as an Experienced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Paget Disease of the Breast, Familial Prostate Cancer, Ampullary Cancer, and Lung Cancer.
Background: - Pleuropulmonary blastoma (PPB) is a rare fast-growing lung tumor that is associated with other, rare tumor types. Most cases of PPB appear in children younger than 6 years of age. Recently, it has been shown that this condition can be inherited (e.g., mutation of the DICER1 gene). Researchers are studying both clinical and genetic aspects of this newly described condition. They are interested in...
Summary: This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, radiation, stem cell transplantation, and immunotherapy works for treating children with newly diagnosed high-risk neuroblastoma. Dinutuximab is a monoclonal antibody that binds to a molecule called GD2, which is found on the surface of neur...